UBS Group’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-16,333
Closed -$135K 8109
2018
Q4
$135K Buy
+16,333
New +$156K ﹤0.01% 5281
2015
Q1
Sell
-1,299
Closed -$10K 9308
2014
Q4
$10K Buy
+1,299
New +$9.48K ﹤0.01% 8399

Other funds holding SEM

UBS Group's SEM Position: Q1 2026 in Review

UBS Group increased its Select Medical (SEM) stake by 36% in Q1 2026, buying an estimated $1.07M and bringing the position to 257,440 shares worth $4.19M. The position accounts for ﹤0.01% of the portfolio, ranked #4251.

UBS Group first reported a position in SEM in Q4 2014 and has held it in 46 quarters since. The position peaked at $8.74M in Q4 2024. 277 funds tracked by Wall St. Rank hold SEM as of Q1 2026.

  • UBS Group held 257,440 shares of Select Medical worth $4.19M as of Q1 2026.
  • UBS Group bought 68,647 Select Medical shares in Q1 2026, an estimated $1.07M.
  • Select Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4251 holding.
  • UBS Group first reported a position in Select Medical in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Select Medical position peaked at $8.74M in Q4 2024.
  • 277 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.